15. Tabellenverzeichnis – Actinic keratosis and squamous cell carcinoma of the skin

Version 2.0 · December 2022 · AWMF 032/022OL
Leitlinienprogramm Onkologie · Deutsche Krebsgesellschaft · Deutsche Krebshilfe · AWMF

Beteiligte Fachgesellschaften und Organisationen

Age-standardized incidence rate for SCC of the skin for regions with coverage judged to be sufficiently high and stable (per 100,000 persons and year, old European standard)

Crude incidence rates as projected case numbers in Germany in 2014-2018

TNM classification of SCC of the skin for the labial skin (excluding lip vermilion), trunk, upper extremities and shoulders, lower extremities, and hip and scrotum (8th edition, 2017)

TNM classification of SCC of the head and neck according to AJCC / UICC (8th edition, 2017)

Factors to consider when making treatment decisions for AK*

Lesion-directed and field-directed therapy methods in AK

Therapy duration of interventions for AK

Overview of the included single studies on cryosurgery

Overview of included individual studies on chemoexfoliation

Individual studies on potassium hydroxide

Overview of the included single studies on ablative laser therapy

Overview of individual studies on diclofenac sodium 3% gel

Overview of included individual studies on 5-FU (concentration 5%)

Overview of included individual studies on 5-FU (concentration 0.5%).

Overview of included individual studies on 5-FU with SA

Overview of individual studies on imiquimod 5%

Overview of individual studies on imiquimod 3.75%

Overview of included single studies on tirbanibulin

Overview of included individual studies on MAL-PDT

Overview of included individual studies on ALA-PDT

Overview of included individual studies on daylight PDT

Overview of the included individual studies for the immunosuppressed subgroup

Overview of individual studies on other topicals

Overview of the included single studies on retinoids

Balance sheet of ablative and physical procedures

Balance sheet drug interventions

Therapy methods for cheilitis actinica

Balance sheet interventions for cheilitis actinica

Adverse events of the comparison cryosurgery vs. MAL red light PDT vs. placebo vs. 5-fluorouracil 5% cream for the treatment of Bowen's disease

Ongoing therapeutic trials with the use of PD1 blockers in cutaneous SCC (FUI = follow-up interval)

Therapeutic studies on the use of chemotherapeutic agents, interferon alpha, and 13-cis retinoic acid in cutaneous SCC

Therapeutic studies with the use of EGFR blockers in cutaneous SCC

Sensitivity and specificity of imaging techniques

Overview of occupational skin cancer

Quality Indicator

Changes in Version 2.01